Uniphar Pakistan × Varifarma × Kemex
Combining international product and manufacturing capabilities with Uniphar’s market development, regulatory and commercialization capabilities.
Uniphar Pakistan has partnered with Varifarma and Kemex in Argentina to develop opportunities in oncology, specialty pharmaceuticals and complex therapies. These partnerships strengthen our ability to offer a broader portfolio spanning established oncology products, complex therapies and selected biosimilar opportunities.
How our partnerships work
The objective is not simply to introduce products, but to build sustainable pharmaceutical businesses around carefully selected therapies and markets.
- Stage 1
Portfolio identification and prioritization
- Stage 2
Product and dossier evaluation
- Stage 3
Regulatory pathway and registration planning
- Stage 4
Market access and pricing strategy
- Stage 5
Distributor and commercial-channel development
- Stage 6
Launch planning and field execution
- Stage 7
Supply planning and lifecycle management
Meet our Argentine partners
An Argentine pharmaceutical company with a strong focus on oncology, hematology, onco-hematology, rare diseases and other complex therapies.
- Oncology
- Onco-hematology
- Hematology
- Rare diseases
An Argentine pharmaceutical company focused on specialty therapies — particularly oncology — producing injectable, liquid, lyophilized and oral solid dosage forms.
- Oncology injectables
- Lyophilized
- Oral solids
- Liquids
Partner with Uniphar
We welcome pharmaceutical companies, biotechnology companies, manufacturers, distributors and investors seeking opportunities in oncology, biosimilars and specialty pharmaceuticals.